AG2R LA Mondiale Gestion D Actifs Buys Shares of 2,963 Axon Enterprise, Inc $AXON

Key Points

• AG2R LA Mondiale Gestion D Actifs acquired 2,963 shares of Axon Enterprise, Inc valued at approximately $1.56 million during the first quarter.
• Insider sales included significant transactions by Jeffrey C. Kunins and Joshua Isner, with total sales amounting to over $17 million.
• Axon reported earnings of $2.12 EPS for the last quarter, exceeding analysts' expectations by $0.58 and a revenue increase of 32.6% year-over-year.

AG2R LA Mondiale Gestion D Actifs bought a new stake in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 2,963 shares of the biotechnology company's stock, valued at approximately $1,558,000.

Other institutional investors have also added to or reduced their stakes in the company. Kentucky Retirement Systems Insurance Trust Fund purchased a new position in Axon Enterprise during the 1st quarter valued at about $1,110,000. Quotient Wealth Partners LLC purchased a new position in Axon Enterprise during the 1st quarter valued at about $438,000. CX Institutional purchased a new position in Axon Enterprise during the 1st quarter valued at about $115,000. GAMMA Investing LLC increased its position in Axon Enterprise by 11.8% during the 1st quarter. GAMMA Investing LLC now owns 1,454 shares of the biotechnology company's stock valued at $765,000 after purchasing an additional 154 shares during the period. Finally, DAVENPORT & Co LLC boosted its holdings in shares of Axon Enterprise by 5.1% in the 1st quarter. DAVENPORT & Co LLC now owns 940 shares of the biotechnology company's stock valued at $494,000 after buying an additional 46 shares in the last quarter. Hedge funds and other institutional investors own 79.08% of the company's stock.

Insider Buying and Selling

In other Axon Enterprise news, insider Jeffrey C. Kunins sold 7,891 shares of the firm's stock in a transaction that occurred on Thursday, August 14th. The shares were sold at an average price of $750.10, for a total transaction of $5,919,039.10. Following the completion of the transaction, the insider directly owned 144,538 shares of the company's stock, valued at approximately $108,417,953.80. This trade represents a 5.18% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, President Joshua Isner sold 15,919 shares of the firm's stock in a transaction that occurred on Friday, August 15th. The stock was sold at an average price of $746.26, for a total transaction of $11,879,712.94. Following the transaction, the president directly owned 238,379 shares of the company's stock, valued at $177,892,712.54. This represents a 6.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 44,790 shares of company stock worth $34,304,947 over the last ninety days. Company insiders own 4.40% of the company's stock.

Axon Enterprise Stock Up 0.7%

AXON stock opened at $756.13 on Friday. The firm has a 50 day moving average of $761.10 and a 200 day moving average of $687.25. The stock has a market capitalization of $59.36 billion, a PE ratio of 186.70, a price-to-earnings-growth ratio of 27.57 and a beta of 1.40. The company has a quick ratio of 2.71, a current ratio of 2.95 and a debt-to-equity ratio of 0.63. Axon Enterprise, Inc has a 52 week low of $375.71 and a 52 week high of $885.91.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last released its earnings results on Monday, August 4th. The biotechnology company reported $2.12 EPS for the quarter, topping analysts' consensus estimates of $1.54 by $0.58. The company had revenue of $668.54 million during the quarter, compared to analysts' expectations of $641.77 million. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. Axon Enterprise's revenue for the quarter was up 32.6% on a year-over-year basis. During the same period last year, the business earned $1.20 EPS. Axon Enterprise has set its FY 2025 guidance at EPS. Sell-side analysts forecast that Axon Enterprise, Inc will post 5.8 earnings per share for the current year.

Wall Street Analyst Weigh In

AXON has been the topic of a number of recent analyst reports. Wolfe Research initiated coverage on shares of Axon Enterprise in a report on Monday, July 7th. They issued an "outperform" rating on the stock. Raymond James Financial restated an "outperform" rating and issued a $855.00 price target (up from $645.00) on shares of Axon Enterprise in a report on Tuesday, August 5th. Northland Securities set a $800.00 price target on shares of Axon Enterprise in a report on Tuesday, August 5th. UBS Group restated a "neutral" rating and issued a $840.00 price target (up from $820.00) on shares of Axon Enterprise in a report on Tuesday, August 5th. Finally, Needham & Company LLC set a $870.00 price target on shares of Axon Enterprise and gave the company a "buy" rating in a report on Tuesday, August 5th. Thirteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, Axon Enterprise has an average rating of "Moderate Buy" and an average target price of $837.69.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.